Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 1,778.60 ($21.93) and last traded at GBX 1,772 ($21.85), with a volume of 430 shares changing hands. The stock had previously closed at GBX 1,756.80 ($21.66).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 0.9 %
The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The business's fifty day moving average price is GBX 1,664.11 and its 200 day moving average price is GBX 1,600.47. The company has a market capitalization of £5.24 billion and a P/E ratio of -1,610.91.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
(
Get Free Report)
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation wasn't on the list.
While First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
